Noticias y Actividades de Full-Life Technologies
Presencia
Sede: Estados Unidos
Fusión, adquisición y financiación con participación de Full-Life Technologies.
- Full-Life Technologies acaba de anunciar una recaudación de fondos de 150 millones de dólares. (publicado el 20 de mayo de 2026).
Ejecutivos
Ver el organigrama con sus 21 ejecutivos principales
Biografías más buscadas en Full-Life Technologies
- Lanny Sun, Co-Founder, Chairman and Chief Executive Officer
- Gaopeng Chen, Director
- Trency Gu, Director
Crear su alerta
para seguir los movimientos de los ejecutivos en Full-Life Technologies.
Equipos médicos
Full-Life Technologies tiene 1.235 competidores entre los que se incluyen Thermo Fisher Scientific (Estados Unidos), Medtronic (Irlanda) y Philips (Países Bajos).
Popular M&A news in Equipos médicos
- Niowave acaba de anunciar una recaudación de fondos de 70 millones de dólares. (publicado el 2 de junio de 2026).
- El nuevo nombre de Edap Tms es FocalTherics. (publicado el 1 de junio de 2026).
- FocalTherics cotiza ahora en bolsa con el símbolo FOCL. (publicado el 31 de mayo de 2026).
Otros contactos sugeridos en el sector Equipos médicos
Noticias
Últimos comunicados de prensa de Full-Life Technologies
- Full-Life Technologies to Participate in the 43rd Annual J.P. Morgan Healthcare Conference-Press Releases-From Half-Life to Full-Life.Full-Life Technologies to Participate in the 43rd Annual J.P. Morgan Healthcare Conference-Press Releases-From Half-Life
- Full-Life Technologies Announced the Progress of its Radioisotope Manufacturing Facility in Belgium-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Announced the Progress of its Radioisotope Manufacturing Facility in Belgium-Press Releas
- Full-Life Technologies to Present Three Top Rated Oral Presentations at the 37th Annual Congress of the European Association of Nuclear Medicine-Press Releases-From Half-Life to Full-Life.Full-Life Technologies to Present Three Top Rated Oral Presentation
- Full-Life Technologies Announces the Appointment of Edward (Ted) Myles to Its Board of Directors-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Announces the Appointment of Edward (Ted) Myles to Its Board of Directors-Press Releases-Fro
- Full-Life Technologies, SK Biopharmaceuticals Enter Licensing Agreement for Novel Therapeutic Targeting Multiple Solid Tumors-Press Releases-From Half-Life to Full-Life.Full-Life Technologies, SK Biopharmaceuticals Enter Licensing Agreement for Novel Ther
- Full-Life Technologies Granted FDA Fast Track Designation for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Granted FDA Fast Track Designation for 225Ac-
- Press Releases-From Half-Life to Full-Life.Press Releases-From Half-Life to Full-Life.
- Full-Life Technologies Announces Clearance from FDA of IND Application for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Announces Clearance from FDA of
- Full-Life Technologies Disclosed Preclinical Data of its NTSR1-targeting RDC Program FL-091 in an Oral Presentation at the 2024 SNMMI Annual Meeting-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Disclosed Preclinical Data of its NTSR1-
- Full-Life Technologies will showcase preclinical data of its NTSR1-targeted RDC program FL-091 in an oral presentation at the 2024 SNMMI Annual Meeting-Press Releases-From Half-Life to Full-Life.Full-Life Technologies will showcase preclinical data of its
- View more press releases Close
Redes sociales sobre Full-Life Technologies
- Full-Life Technologies en Wikipedia, Google News y Yahoo Finance
- Full-Life Technologies en LinkedIn, Twitter y YouTube
